{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:39:07Z","timestamp":1792021147588,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T00:00:00Z","timestamp":1469836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11926-016-0610-z","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T03:46:48Z","timestamp":1469850408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neonatal Lupus: What We Have Learned and Current Approaches to Care"],"prefix":"10.1007","volume":"18","author":[{"given":"Marisa S.","family":"Klein-Gitelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,30]]},"reference":[{"key":"610_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM198501103120206","volume":"3129","author":"SE Litsey","year":"1985","unstructured":"Litsey SE, Noonan JA, O\u2019Connor WN, et al. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med. 1985;3129:98\u2013100.","journal-title":"N Engl J Med"},{"issue":"6","key":"610_CR2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","volume":"142","author":"R Cimaz","year":"2003","unstructured":"Cimaz R, Spence DL, Hornberger L, et al. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003;142(6):678\u201383. This article is a prospective study which describes the incidence and types of neonatal lupus born to mothers with anti-Ro antibodies. Most data are from registries.","journal-title":"J Pediatr"},{"issue":"1","key":"610_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(81)70011-2","volume":"4","author":"HL Franco","year":"1981","unstructured":"Franco HL, Weston WL, Peebles C, et al. Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol. 1981;4(1):67\u201372.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"610_CR4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/mpd.2000.109108","volume":"137","author":"AR Neiman","year":"2000","unstructured":"Neiman AR, Lee LA, Weston WL, et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr. 2000;137(5):674\u201380.","journal-title":"J Pediatr"},{"issue":"4","key":"610_CR5","first-page":"251","volume":"45","author":"C Bouderlique","year":"1990","unstructured":"Bouderlique C, Debillon T, Mesnard B, et al. Neonatal lupus presenting as telangiectasic and atrophic lesions. Pediatrie. 1990;45(4):251\u20134. Article in French 2.","journal-title":"Pediatrie"},{"issue":"5","key":"610_CR6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0961203311430701","volume":"21","author":"RM Guinovart","year":"2012","unstructured":"Guinovart RM, Vicente A, Rovira C, et al. Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus. Lupus. 2012;21(5):552\u20135.","journal-title":"Lupus"},{"key":"610_CR7","unstructured":"Lin C, Shyur SD, Wu JY, et al.: Facial telangiectasia\u2014an unusual complication of neonatal lupus erythematosus: report of one case. Acta Paediatr. Taiwan. 2004;45 (4):246\u2013248."},{"issue":"1","key":"610_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0190-9622(95)90004-7","volume":"33","author":"CM Thornton","year":"1995","unstructured":"Thornton CM, Eichenfield LF, Shinall EA, et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol. 1995;33(1):19\u201325.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"610_CR9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/pde.12088","volume":"30","author":"K Heelan","year":"2013","unstructured":"Heelan K, Watson R, Collins SM. Neonatal lupus syndrome associated with ribonucleoprotein antibodies. Pediatr Dermatol. 2013;30(4):416\u201323.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"610_CR10","volume":"109","author":"LA Lee","year":"2002","unstructured":"Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics. 2002;109(1), E11.","journal-title":"Pediatrics"},{"key":"610_CR11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1177\/0961203313509294","volume":"22","author":"CC Chen","year":"2013","unstructured":"Chen CC, Lin K-L, Chen CL, et al. Central nervous system manifestations of neonatal lupus: a systematic review. Lupus. 2013;22:1484\u20138.","journal-title":"Lupus"},{"key":"610_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0961203309354542","volume":"19","author":"AD Askanase","year":"2010","unstructured":"Askanase AD, Izmirly PM, Katholi M, et al. Frequency of neuro-psychiatric dysfunction in anti-SSA\/SSB exposed children with and without neonatal lupus. Lupus. 2010;19:300\u20136.","journal-title":"Lupus"},{"key":"610_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/apa.12049","volume":"102","author":"A Skog","year":"2013","unstructured":"Skog A, Tingstrom J, Salomonsson S, et al. Neurodevelopment in children with and without congenital heart block born to anti-Ro\/SSA-positive mothers. Acta Pediatr. 2013;102:40\u20136. This is the only paper that describes neurodevelopmental outcomes of children with in utero anti-Ro antibodies comparing effects of congenital heart block to those children who had healthy hearts.","journal-title":"Acta Pediatr"},{"key":"610_CR14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0961203313501402","volume":"23","author":"C Nalli","year":"2014","unstructured":"Nalli C, Iodice A, Andreoli L, et al. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Lupus. 2014;23:507\u201317.","journal-title":"Lupus"},{"key":"610_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/BOR.0b013e328356226b","volume":"24","author":"PM Izmirly","year":"2012","unstructured":"Izmirly PM, Buyon JP, Saxena A. Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr Opin Rheumatol. 2012;24:466\u201372.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"610_CR16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","volume":"124","author":"PM Izmirly","year":"2011","unstructured":"Izmirly PM, Saxena A, Kim MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus. Circulation. 2011;124(9):1927\u201335. This is an excellent description of factors both from the mother and the fetus that might alter outcomes for cardiac neonatal lupus in a heterogenous population.","journal-title":"Circulation"},{"issue":"5","key":"610_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","volume":"11","author":"P Brito-Seron","year":"2015","unstructured":"Brito-Seron P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301\u201312.","journal-title":"Nat Rev Rheumatol"},{"key":"610_CR18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","volume":"44","author":"A Brucato","year":"2001","unstructured":"Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by couterimmunoelectrophoresis: a prospective study. Arthritis Rheum. 2001;44:1832\u20135.","journal-title":"Arthritis Rheum"},{"key":"610_CR19","first-page":"2187","volume":"50","author":"N Costedoat-Chalumeau","year":"2004","unstructured":"Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, et al. Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 2004;50:2187\u201394.","journal-title":"Arthritis Rheum"},{"key":"610_CR20","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","volume":"60","author":"C Llanos","year":"2009","unstructured":"Llanos C, Izmirly PM, Katholi M, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors. Arthritis Rheum. 2009;60:3091\u20137.","journal-title":"Arthritis Rheum"},{"key":"610_CR21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","volume":"68","author":"TL Rivera","year":"2009","unstructured":"Rivera TL, Izmirly PM, Birnbaum BK, et al. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis. 2009;68:828\u201335.","journal-title":"Ann Rheum Dis"},{"key":"610_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","volume":"50","author":"RM Clancy","year":"2004","unstructured":"Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50:173\u201382.","journal-title":"Arthritis Rheum"},{"key":"610_CR23","first-page":"848","volume":"32","author":"M Scarsi","year":"2014","unstructured":"Scarsi M, Radice A, Pregnolato F, et al. Anti-Ro\/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicenter cross-sectional study on behalf of the \u2018Forum Interdisciplinare per la ricerca nelle Malattie Autoimmuni (FIRMA) group. Clin Exp Rheumatol. 2014;32:848\u201354.","journal-title":"Clin Exp Rheumatol"},{"key":"610_CR24","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","volume":"55","author":"E Jaeggi","year":"2010","unstructured":"Jaeggi E, Laskin C, Hamilton R, et al. The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010;55:2778\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"610_CR25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/icb.2011.108","volume":"90","author":"R Lindip","year":"2012","unstructured":"Lindip R, Arentz G, Thurgood LA, et al. Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol Cell Biol. 2012;90:304\u20139.","journal-title":"Immunol Cell Biol"},{"key":"610_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072668","volume":"8","author":"LS Strandberg","year":"2013","unstructured":"Strandberg LS, Cui X, Rath A, et al. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the alpha 1G T-type calcium channel in human fetal hearts. PLoS One. 2013;8, e72668. This paper describes the identification of a calcium channel autoantibody from maternal human serum that could account for changes in the conduction system. It has been unclear to date why anti-SSA\/SSB antibodies specifically target the conduction system.","journal-title":"PLoS One"},{"key":"610_CR27","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.4049\/jimmunol.171.6.3253","volume":"171","author":"RM Clancy","year":"2003","unstructured":"Clancy RM, Backer CB, Yi X, et al. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol. 2003;171:3253\u201361.","journal-title":"J Immunol"},{"key":"610_CR28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(03)14795-2","volume":"362","author":"AM Stevens","year":"2003","unstructured":"Stevens AM, Hermes HM, Rutledge JC, et al. Myocaridal-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet. 2003;362:1617\u201323.","journal-title":"Lancet"},{"key":"610_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/keh453","volume":"44","author":"AM Stevens","year":"2005","unstructured":"Stevens AM, Hermes HM, Lambert NC, et al. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology(Oxford). 2005;44:187\u201391.","journal-title":"Rheumatology(Oxford)"},{"key":"610_CR30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2015.06.1088","volume":"66","author":"A Saxena","year":"2015","unstructured":"Saxena A, Izmirly PM, Han SW, et al. Serum biomarkers of inflammation, fibrosis, and cardiac function in facilitating diagnosis, prognosis, and treatment of anti-SSA\/Ro-associated cardiac neonatal lupus. J Am Coll Cardiol. 2015;66:930\u20139. This is an excellent study describing potential biomarkers that can identify and assess risk for infants exposed to anti-SSA\/Ro antibodies.","journal-title":"J Am Coll Cardiol"},{"key":"610_CR31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","volume":"62","author":"CN Pisoni","year":"2010","unstructured":"Pisoni CN, Brucato A, Ruffatti A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010;62:1147\u201352.","journal-title":"Arthritis Rheum"},{"key":"610_CR32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","volume":"62","author":"DM Friedman","year":"2010","unstructured":"Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as a preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trail. Arthritis Rheum. 2010;62:1138\u201346.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"610_CR33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","volume":"75","author":"PM Izmirly","year":"2015","unstructured":"Izmirly PM, Saxena A, Sahl S, et al. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis. 2015;75(6):1161\u20136. This study demonstrates the lack of utility of fluorinated steroid treatment as an intervention in utero for autoimmune-mediated heart block.","journal-title":"Ann Rheum Dis"},{"key":"610_CR34","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","volume":"110","author":"ET Jaeggi","year":"2004","unstructured":"Jaeggi ET, Fouron JC, Silverman ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542\u20138.","journal-title":"Circulation"},{"key":"610_CR35","doi-asserted-by":"crossref","unstructured":"Brucato A, Ramoni V, Gerosa M et al. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin Obstet Gynecol 2011; 117(177).","DOI":"10.1097\/AOG.0b013e3182042972"},{"key":"610_CR36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","volume":"57","author":"SM Trucco","year":"2011","unstructured":"Trucco SM, Jaeggi E, Cuneo B, et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011;57:715\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"610_CR37","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3109\/14767051003728237","volume":"23","author":"BE Cuneo","year":"2010","unstructured":"Cuneo BE, Lee M, Roberson D, et al. A management strategy for f or fetal immune-mediated atrioventricular block. J Matern Fetal Neonatal Med. 2010;23:1400\u20135. This paper describes a strategy for treating the fetus in utero including a biophysical profile and progression of intervention for heart failure and bradycardia.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"610_CR38","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","volume":"54","author":"ME Clowse","year":"2006","unstructured":"Clowse ME, Madger L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54:3640\u20137.","journal-title":"Arthritis Rheum"},{"key":"610_CR39","doi-asserted-by":"crossref","unstructured":"Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduce risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126976\u201382. This paper describes the decreased rate of autoimmune-mediated heart block in mothers being treated with hydroxychloroquine and prompted the current interventional study of hydroxychloroquine in anti-Ro positive mothers during pregnancy.","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"610_CR40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1651-2227.2011.02563.x","volume":"101","author":"G Bergman","year":"2012","unstructured":"Bergman G, Eliasson H, Mohlkert LA, et al. Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA\/\u2019Ro52 autoantibodies. Acta Paediatr. 2012;101:488\u201393.","journal-title":"Acta Paediatr"},{"key":"610_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/apa.12483","volume":"103","author":"G Bergman","year":"2014","unstructured":"Bergman G, Skog A, Tingstrom J, et al. Late development of complete atrioventricular block may be immune mediated and congenital in origin. Acta Paediatr. 2014;103:275\u201381.","journal-title":"Acta Paediatr"},{"key":"610_CR42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/apa.12248","volume":"102","author":"A Skog","year":"2013","unstructured":"Skog A, Eliasson H, Tingstrom J, et al. Long term growth of children with autoantibody mediated congenital heart block. Acta Paediatr. 2013;102:718\u201326.","journal-title":"Acta Paediatr"},{"key":"610_CR43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.amjcard.2011.03.090","volume":"108","author":"DL Davey","year":"2011","unstructured":"Davey DL, Bratton SL, Bradkley DJ, et al. Relation of maternal anti-Ro\/La antibodies to aortic dilation in patients with congenital complete heart block. Am J Cardiol. 2011;108:561\u20134.","journal-title":"Am J Cardiol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0610-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-016-0610-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-016-0610-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:50:50Z","timestamp":1568231450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-016-0610-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,30]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s11926-016-0610-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,30]]},"article-number":"60"}}